Collegium Pharmaceutical Inc - fluxo de caixa trimestral (NASDAQ:COLL) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Total assets 1.66 B1.63 B1.59 B1.61 B1.66 B Total liabilities 1.43 B1.4 B1.36 B1.33 B1.36 B Total equity 228.84 M234.43 M232.21 M274.81 M301.68 M Total liabilities & shareholders' equities 1.66 B1.63 B1.59 B1.61 B1.66 B Total debt 852.49 M837.71 M822.92 M808.12 M809.33 M Net debt 595.53 M538.35 M495.96 M382.51 M267.22 M

Notícias

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth - Slideshow (NASDAQ:COLL) 2026-03-24

Collegium Pharmaceuticals: Another M&A Episode Adds To An Intriguing Case (NASDAQ:COLL)

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript

Jefferies reitera recomendação de compra para Collegium Pharmaceutical após acordo sobre TDAH

Barclays reitera classificação de ações da Collegium Pharmaceutical como acima da média

Collegium Pharmaceutical adquire AZSTARYS por US$ 650 milhões

Collegium Pharmaceutical, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:COLL) 2026-03-01

Collegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to Say

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Collegium Q4 2025 slides: ADHD drug surges despite earnings miss

Lucro da Collegium Pharmaceutical veio abaixo das projeções por $0,10; receita menor do que estimativas

Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates